Persistent increase of PRL after oral contraceptive treatment

@article{AlvarezTutor1999PersistentIO,
  title={Persistent increase of PRL after oral contraceptive treatment
},
  author={E Alvarez-Tutor and L. Forga-LLenas and Rosa Rodriguez-Erdozain and Mar{\'i}a Jos{\'e} Go{\~n}i-Iriarte and Edelmiro Menendez-Torre and J Alvarez-Tutor},
  journal={Archives of Gynecology and Obstetrics},
  year={1999},
  volume={263},
  pages={45-50}
}
Abstract Background: The mechanism involved in estrogen induced hyperprolactinemia is not completely known, although one of the possible theories suggest inhibition of dopaminergic tone. Our objective was to study the mechanism implied in the increment of PRL levels as a consequence of oral contraceptive treatment and possible modifications in TSH levels. Material and methods: We performed a trial on 21 healthy women, nulliparas. We administered 35 µg of Etinil-Estradiol (EE) and 2 mg of… 
Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats.
TLDR
A long-term study to assess the effects of subcutaneous and orally fed 17beta-estradiol (E2), as well as the actions of resveratrol (RES) on pituitary function in female rats demonstrated that RES binds with a 10-fold lower affinity to estrogen receptor (ER)-alpha than to ERbeta.
Effects of raloxifene, one of the selective estrogen receptor modulators, on pituitary-ovary axis and prolactin in postmenopausal women
TLDR
Long-term administration of raloxifene up to 1 yr decreases serum prolactin level significantly and may be a therapeutic alternative for postmenopausal osteoporotic women with hyperprolactinemia.
Chronic estrogen affects TIDA neurons through IL-1β and NO: effects of aging.
TLDR
Results show that chronic exposure to low levels of E2 decreases TIDA activity through a cytokine-nitric oxide-mediated pathway leading to hyperprolactinemia and that aging could promote these degenerative changes.
The effect of long-term antipsychotic treatment on prolactin.
  • J. Staller
  • Psychology, Medicine
    Journal of child and adolescent psychopharmacology
  • 2006
TLDR
The risk of hyperprolactinemia with long-term use of risperidone appears to be significantly greater than for olanzapine or quetiapine, and Overt side effects were infrequent in the overall sample, but serum prolactin assessment is recommended for youths taking risperidine chronically.
Impact of oral contraceptives and breastfeeding on disease activity in a sample of Egyptian rheumatoid arthritis patients
TLDR
Oral contraceptives may be considered in RA female patients not only as a suitable birth control method but also it has a controlling effect on disease activity even during lactation.
Hyperprolactinaemia
TLDR
An update on the diagnostic and management approaches for the patient with hyperprolactinaemia and on the current data looking at the impact of high prolactin on metabolism, cardiovascular and immune systems is provided.
PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
TLDR
Current knowledge on prolactin physiology, etiopathogenesis, clinical features, assessment, differential diagnosis, and teatment of hyperprolactinaemia in the female patient are reviewed.
Polymorphisms in oestrogen and progesterone receptor genes: possible influence on prolactin levels in women
TLDR
This study investigates the possible influence of polymorphisms of the genes encoding the oestrogen receptor, ERα, ERβ and the progesterone receptor, on prolactin levels in premenopausal women.
Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users
TLDR
Data do not support the premise that recreational ecstasy/MDMA use results in measurable impairment of serotonergic control of endocrine activity, and the relationship between extent of ecstasy use and neuroendocrine functioning, alone or in combination with potential confounding variables.
Variation of female prolactin levels with menopausal status and phase of menstrual cycle
TLDR
The aim of this study was to determine the degree of variability of prolactin in these physiological states: menstrual cycle and menopause.
...
1
2
...

References

SHOWING 1-10 OF 21 REFERENCES
[Prolactin stimulation using the metoclopramide test in females taking oral contraceptives].
In 31 patients taking oral contraceptives (o.c.) for a period between 1 year to more than 3 years, basal serum prolactin levels and metoclopramide induced prolactin values were determined 30 and 60
PROLACTIN LEVELS AND PITUITARY ENLARGEMENT IN HORMONE‐TREATED MALE‐TO‐FEMALE TRANSSEXUALS
TLDR
The data suggest that the lowest possible oestrogen dose and lifelong follow-up of hormone‐treated male‐to‐female transsexuals is essential.
Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
TLDR
Treatment of hirsutism with low estrogen oral contraceptives containing nonandrogenic or anti androgenic progestogen is very effective, 2 years for best results, and changes in plasma lipids are of some concern but of difficult interpretation.
Hyperprolactinemia in girls with idiopathic precocious puberty under prolonged treatment with cyproterone acetate.
TLDR
The results suggest that in idiopathic precocious puberty the action of CA upon the hypothalamic-hypophyseal complex is not solely antigonadotropic and that prolactin secretion is enhanced in patients given this drug.
Effects of gonadotropin-releasing hormone agonist and clomiphene citrate on estrogen/progesterone-induced hyperprolactinemia in monkeys.
TLDR
Neither GnRH-a nor CC had an overall effect on E2/P-induced hyperprolactinemia, suggesting that leuprolide may exert a delayed stimulatory effect on PRL secretion, or that complete suppression of the putative paracrine regulation of PRL stimulation may require more than 13 days of Gn RH-a administration.
Role of ovarian sex steroids in the regulation of thyrotropin (TSH) secretion of hypogonadal women.
TLDR
In the unstimulated secretory profiles, TSH was found to be episodically released, with little interindividual variability for each study condition, and the episodic character of TSH secretion virtually remained unchanged by sex steroid replacements.
Effect of estrogens on prolactin secretion in transsexual subjects
TLDR
Treatment of male transsexuals with high doses of estradiol in its conjugate forms must be viewed with caution because there exist both time and dose thresholds for effective enhancement of prolactin secretion by estrogen.
Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
The pharmacokinetics of levonorgestrel (LNG) and ethinylestradiol (EE2) were determined in 9 healthy women (age 23 to 42 years), during a treatment period of three months with a low-dose oral
DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPHIN (TSH) SECRETION IN NORMAL MAN
Using a sensitive and precise radioimmunoassay for human TSH we have demonstrated significant elevations in serum TSH levels in euthyroid volunteers following administration of the dopamine receptor
Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe.
TLDR
It is demonstrated that E2 stimulates NIL cells to release an activity that enhances PRL secretion in two ways: 1) by recruiting additional PRL cells into the secretory pool, and 2) by augmenting thesecretory capacity of individual PRL Cells.
...
1
2
3
...